Super-TDU (1-31) (TFA)


Catalog No. Size PriceQuantity
M12122-2 Contact sales@xcessbio.com for quotation $100
M12122-10 Contact sales@xcessbio.com for quotation $100

Description

Super-TDU (1-31) is a peptide of Super-TDU, which is an inhibitor of YAP-TEADs, shows potent anti-tumor activity.

Product information

Molecular Weight: 3355.50

Formula: C143H219F3N40O50

Chemical Name: (3S, 9S, 12S, 15S, 18R, 21S, 24S, 27S, 30S)-24-((1H-imidazol-5-yl)methyl)-3-((3S, 9S, 18S, 21S, 24S, 27S, 30S, 31S)-27-((1H-indol-3-yl)methyl)-1-amino-3-((S)-2-((3S, 6S, 9R, 12S, 15S)-19-amino-3-((S)-2-((S)-5-amino-1-((1S, 2S)-1-carboxy-2-hydroxypropylamino)-1, 5-dioxopentan-2-ylcarbamoyl)pyrrolidine-1-carbonyl)-6-(2-amino-2-oxoethyl)-12-((S)-1-hydroxyethyl)-2, 9-dimethyl-5, 8, 11, 14-tetraoxo-4, 7, 10, 13-tetraazanonadecan-15-ylcarbamoyl)pyrrolidine-1-carbonyl)-21-(3-amino-3-oxopropyl)-18-sec-butyl-31-hydroxy-9-(hydroxymethyl)-24-isobutyl-1, 5, 8, 11, 14, 17, 20, 23, 26, 29-decaoxo-4, 7, 10, 13, 16, 19, 22, 25, 28-nonaazadotriacontan-30-ylcarbamoyl)-30-((S)-2-((S)-2-amino-3-hydroxypropanamido)-3-methylbutanamido)-15-(4-aminobutyl)-21-benzyl-27-(carboxymethyl)-12-(hydroxymethyl)-9-isobutyl-18-methyl-5, 8, 11, 14, 17, 20, 23, 26, 29-nonaoxo-4, 7, 10, 13, 16, 19, 22, 25, 28-nonaazadotriacontane-1, 32-dioic acid compound with 2, 2, 2-trifluoroacetic acid (1:1)

Smiles: CC[C@@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](C)NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@H](C)O)C(O)=O.OC(=O)C(F)(F)F

InChiKey: OSKJKOAHQPZHGY-VLKIPGASSA-N

InChi: InChI=1S/C141H218N40O48.C2HF3O2/c1-16-68(10)111(135(222)154-56-102(192)151-57-103(193)160-94(61-183)119(206)153-59-105(195)159-93(50-101(148)191)139(226)180-42-26-34-96(180)133(220)163-81(33-23-25-41-143)121(208)177-112(71(13)185)137(224)157-70(12)116(203)165-89(49-100(147)190)130(217)175-110(67(8)9)140(227)181-43-27-35-97(181)134(221)164-83(37-39-99(146)189)123(210)179-114(73(15)187)141(228)229)176-122(209)82(36-38-98(145)188)162-125(212)85(45-65(4)5)167-126(213)87(47-75-54-150-79-31-21-20-30-77(75)79)171-138(225)113(72(14)186)178-131(218)90(51-106(196)197)158-104(194)58-152-118(205)84(44-64(2)3)166-132(219)95(62-184)173-120(207)80(32-22-24-40-142)161-115(202)69(11)156-124(211)86(46-74-28-18-17-19-29-74)168-127(214)88(48-76-55-149-63-155-76)169-128(215)91(52-107(198)199)170-129(216)92(53-108(200)201)172-136(223)109(66(6)7)174-117(204)78(144)60-182;3-2(4,5)1(6)7/h17-21,28-31,54-55,63-73,78,80-97,109-114,150,182-187H,16,22-27,32-53,56-62,142-144H2,1-15H3,(H2,145,188)(H2,146,189)(H2,147,190)(H2,148,191)(H,149,155)(H,151,192)(H,152,205)(H,153,206)(H,154,222)(H,156,211)(H,157,224)(H,158,194)(H,159,195)(H,160,193)(H,161,202)(H,162,212)(H,163,220)(H,164,221)(H,165,203)(H,166,219)(H,167,213)(H,168,214)(H,169,215)(H,170,216)(H,171,225)(H,172,223)(H,173,207)(H,174,204)(H,175,217)(H,176,209)(H,177,208)(H,178,218)(H,179,210)(H,196,197)(H,198,199)(H,200,201)(H,228,229);(H,6,7)/t68-,69-,70-,71+,72+,73+,78+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,96+,97+,109+,110+,111+,112+,113+,114+;/m1./s1

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: To be determined

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

References:

  1. Jiao S, et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell. 2014 Feb 10;25(2):166-80.

Products are for research use only. Not for human use.

Payment & Security

PayPal Venmo

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed